These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18072814)

  • 41. Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.
    Rasmussen H; Ebdrup BH; Erritzoe D; Aggernaes B; Oranje B; Kalbitzer J; Pinborg LH; Baaré WF; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):583-92. PubMed ID: 20614105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.
    Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R
    Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quetiapine: a well-tolerated and effective atypical antipsychotic.
    Hellewell JS
    Hosp Med; 2002 Oct; 63(10):600-3. PubMed ID: 12422494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of high doses of quetiapine in bipolar disorder episodes are not linked to high activity of cytochrome P4503A4 and/or cytochrome P4502D6.
    Khazaal Y; Preisig M; Chatton A; Kaufmann N; Bilancioni R; Eap CB
    Psychiatr Q; 2013 Sep; 84(3):329-35. PubMed ID: 23230007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosing and switching strategies for quetiapine fumarate.
    Cutler AJ; Goldstein JM; Tumas JA
    Clin Ther; 2002 Feb; 24(2):209-22. PubMed ID: 11911552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the effectiveness of aripiprazole and quetiapine in schizophrenia and related psychoses: a naturalistic, retrospective chart review study.
    Shajahan P; Keith S; Majjiga C; Murphy J; MacRae A; Bashir M; Taylor M
    J Clin Psychiatry; 2009 May; 70(5):692-8. PubMed ID: 19284930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quetiapine. A review of its use in the management of schizophrenia.
    Cheer SM; Wagstaff AJ
    CNS Drugs; 2004; 18(3):173-99. PubMed ID: 14871161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose response and atypical antipsychotics in schizophrenia.
    Kinon BJ; Ahl J; Stauffer VL; Hill AL; Buckley PF
    CNS Drugs; 2004; 18(9):597-616. PubMed ID: 15222776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder.
    Margolese HC; Chouinard G; Beauclair L; Bélanger MC
    J Clin Psychopharmacol; 2002 Aug; 22(4):347-52. PubMed ID: 12172332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quetiapine--efficacy in different domains.
    Sharma T
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S385-90. PubMed ID: 11587885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial.
    Sacchetti E; Panariello A; Regini C; Valsecchi P
    Schizophr Res; 2004 Aug; 69(2-3):325-31. PubMed ID: 15469204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quetiapine extended release for the treatment of bipolar disorder.
    Samalin L; Tremey A; Llorca PM
    Expert Rev Neurother; 2014 Sep; 14(9):987-1005. PubMed ID: 25096854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How dosing of ziprasidone in a state hospital system differs from product labeling.
    Citrome L; Jaffe A; Levine J
    J Clin Psychiatry; 2009 Jul; 70(7):975-82. PubMed ID: 19653974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quetiapine-induced myoclonus.
    Velayudhan L; Kirchner V
    Int Clin Psychopharmacol; 2005 Mar; 20(2):119-20. PubMed ID: 15729090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.